FDA: Breakthrough Therapy Designation: An Analysis of the Past Two and a Half Years CDER Breakthrough Therapy Designation: Two-and-a-Half Years In Posted on the FDA website on 19 May 2015 editor2015-05-24T11:21:38+00:0025.05.2015|Drug Development Strategy, Regulatory Affairs| Comparta esta información, escoja su plataforma FacebookTwitterLinkedInEmail
